Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients
This study has been completed.
Study NCT01224028   Information provided by Astellas Pharma Inc

First Received on October 18, 2010.   Last Updated on October 6, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
IgA Nephropathy
Additional conditions recognized in this trial
Glomerulonephritis, IGA
Kidney Diseases
More general conditions related to this trial
Autoimmune Diseases
Glomerulonephritis
Immune System Diseases
Nephritis
Urologic Diseases
Interventions listed in this trial
Tacrolimus
Placebo
More general drug interventions related to this trial
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Astellas Pharma Inc
Astellas Pharma Korea, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services